To explain the higher frequency of KIR2DL2-HLA-C1 in younger HCC patients, we considered that NK-cell activation was inhibited by KIR2DL1-HLA-C1, thus rendering them unable to kill HCC cells. Here, KIR2DL1 is linked to hepatocellular carcinoma.